Canton Hathaway’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-25
Closed -$5K 311
2021
Q1
$5K Buy
+25
New +$5.8K ﹤0.01% 294
2019
Q3
Sell
-870
Closed -$58K 233
2019
Q2
$58K Buy
+870
New +$50.7K 0.03% 116

Other funds holding TDOC

Canton Hathaway's TDOC Position: Q2 2021 in Review

Canton Hathaway sold out of Teladoc Health (TDOC) in Q2 2021, closing a stake of 25 shares — an estimated $5K sold.

Canton Hathaway first reported a position in TDOC in Q2 2019 and held it in 2 quarters. The position peaked at $58K in Q2 2019. 829 funds tracked by Wall St. Rank hold TDOC as of Q2 2021.

  • Canton Hathaway reported no remaining Teladoc Health position as of Q2 2021 after selling out during the quarter.
  • Canton Hathaway sold 25 Teladoc Health shares in Q2 2021, an estimated $5K.
  • Canton Hathaway first reported a position in Teladoc Health in Q2 2019 and held it in 2 quarters.
  • Canton Hathaway's Teladoc Health position peaked at $58K in Q2 2019.
  • 829 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2021.

Based on Canton Hathaway's 13F filing for Q2 2021, filed 8 Jul 2021.